Gestational Diabetes Research and Management
Gestational Diabetes Research and Management is a research topic within Obstetrics and Gynecology. Science Explorer counts 36k research works in it since 1950. 23.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the impact of gestational diabetes mellitus (GDM) and related factors such as maternal obesity, hyperglycemia, and metabolic syndrome on pregnancy outcomes, fetal development, and long-term health implications for both mothers and offspring. It covers topics such as diagnosis, classification, treatment, prevention, and long-term consequences of GDM, as well as the association with type 2 diabetes and cardiovascular disease. Additionally, it investigates the influence of maternal weight gain, macrosomia, and metabolic imprinting on offspring health.
- Gestational Diabetes Mellitus
- Maternal Obesity
- Pregnancy Outcomes
- Type 2 Diabetes
- Metabolic Syndrome
- Maternal Weight Gain
- Fetal Development
- Adverse Pregnancy Outcomes
- Hyperglycemia
- Offspring Health
- Research works
- 36k fractional, since 1950
- In the world top 10%
- 8.4k per year above
- Top-10% rate
- 23.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +40% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Gestational Diabetes Research and Management research?
By volume, the United States and China publish the most (1.5k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 1.2k works
- 3 India 462 works
- 4 United Kingdom 365 works
- 5 Australia 295 works
- 6 Brazil 287 works
- 7 Canada 281 works
- 8 Türkiye 223 works
- 9 Iran 169 works
- 10 Japan 164 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Gestational Diabetes Research and Management research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Gestational Diabetes Research and Management research, followed by Harvard University and Peking University.
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 39 works
- 2 Harvard UniversityUnited States 28 works
- 3 Peking UniversityChina 27 works
- 4 Sağlık Bilimleri ÜniversitesiTürkiye 26 works
- 5 Northwestern UniversityUnited States 23 works
- 6 University of PittsburghUnited States 21 works
- 7 Oregon Health & Science UniversityUnited States 20 works
- 8 Sichuan UniversityChina 20 works
- 9 The Ohio State UniversityUnited States 20 works
- 10 Women's Hospital, School of Medicine, Zhejiang UniversityChina 20 works
Who are the leading researchers in Gestational Diabetes Research and Management?
The most-cited researchers publishing on Gestational Diabetes Research and Management include Cyrus Cooper, Zulfiqar A Bhutta and Luca Ronfani.
- 1 Cyrus Cooper United Kingdom 7.2k citations
- 2 Zulfiqar A Bhutta Pakistan 7k citations
- 3 Luca Ronfani Italy 5.5k citations
- 4 George Davey Smith United Kingdom 4.9k citations
- 5 Mark I. McCarthy United Kingdom 4.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Gestational Diabetes Research and Management research done?
The largest centres of Gestational Diabetes Research and Management research in 2022–2025 are Beijing (China), London (United Kingdom), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Aurora, Portland and Providence.
Largest cities, 2022–2025
Where it is the local speciality
- AuroraUS · 22.2 works7.2×
- PortlandUS · 27.9 works5.6×
- ProvidenceUS · 23.3 works4.9×
- EvanstonUS · 26.6 works4.9×
Location quotient: how much more of its research is in Gestational Diabetes Research and Management than the world average.
Where is the best place to study Gestational Diabetes Research and Management?
Among universities, judged by research, University of Gondar, China Medical University and Monash University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of GondarEthiopia | 62.3 | 45.6% | 7.9× | 9 | +127.0% |
| 2 | China Medical UniversityChina | 59.9 | 40.8% | 6.8× | 16 | +75.0% |
| 3 | Monash UniversityAustralia | 59.7 | 40.6% | 2.9× | 18 | +130.6% |
| 4 | University of Colorado Anschutz Medical CampusUnited States | 59.4 | 27.4% | 7.2× | 15 | +621.7% |
| 5 | Medical University of LublinPoland | 59.0 | 43.2% | 8.3× | 10 | +64.7% |
| 6 | Karolinska InstitutetSweden | 58.8 | 33.3% | 5.6× | 19 | +21.7% |
| 7 | Northwestern UniversityUnited States | 58.4 | 26.6% | 4.6× | 23 | +183.6% |
| 8 | Harvard UniversityUnited States | 55.8 | 36.5% | 2.9× | 28 | +34.2% |
| 9 | Pomeranian Medical UniversityPoland | 55.1 | 20.6% | 14.0× | 8 | +506.3% |
| 10 | Oregon Health & Science UniversityUnited States | 53.3 | 18.9% | 9.0× | 20 | +36.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Gestational Diabetes Research and Management research growing?
Output in 2018–2022 was 40% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Gestational Diabetes Research and Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.